Our prior researches have similarly demonstrated that gypenosides could ameliorate hepatic inflammation in high-fat diet induced NAFLD rats by attenuating the LPS/TLR4/MyD88/NF-κB signaling pathway (Shen et al. 2020, 2022). Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.